Mediators of lung injury in mice following systemic activation of complement. 1985

H W Tvedten, and G O Till, and P A Ward

Acute lung injury has been produced in mice by the intravenous injection of cobra venom factor. The marked attenuation of lung injury in C5-deficient mice indicates an absolute requirement for C5 in the development of lung injury. Similar studies carried out in beige mice suggest that leukocytic proteinases play, at best, a limited role in the injury. Neutrophil or platelet depletion resulted in a marked reduction in the extent of lung injury, suggesting that both platelets as well as neutrophils contribute to the injury. Treatment of mice with catalase provided a marked degree of protection from the lung injury, while treatment with superoxide dismutase produced limited protection, which suggests that H2O2 or its derivatives are involved in the induction of acute lung injury. By the use of transmission electron microscopy, areas of lung vascular injury, as manifested by extensive blebbing of endothelial cells, were associated with intravascular aggregates of platelets, neutrophils, and fibrin. Finally, lipoxygenase and thromboxane synthetase inhibitors afforded some protection against cobra venom factor-induced acute lung injury, while cyclooxygenase inhibitors gave variable results. These data suggest that acute lung injury in mice following systemic activation of complement has an absolute requirement for C5, is dependent on a role of both neutrophils as well as platelets, and can be linked to the generation of toxic oxygen products by neutrophils.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H W Tvedten, and G O Till, and P A Ward
January 1986, Federation proceedings,
H W Tvedten, and G O Till, and P A Ward
January 1999, Journal of vascular research,
H W Tvedten, and G O Till, and P A Ward
January 1985, Progress in biochemical pharmacology,
H W Tvedten, and G O Till, and P A Ward
August 1985, The Journal of clinical investigation,
H W Tvedten, and G O Till, and P A Ward
January 1985, Federation proceedings,
H W Tvedten, and G O Till, and P A Ward
June 1987, The Journal of rheumatology. Supplement,
H W Tvedten, and G O Till, and P A Ward
July 2004, Clinical and experimental immunology,
H W Tvedten, and G O Till, and P A Ward
December 2006, Clinica chimica acta; international journal of clinical chemistry,
H W Tvedten, and G O Till, and P A Ward
May 2012, The Journal of pharmacology and experimental therapeutics,
H W Tvedten, and G O Till, and P A Ward
August 1987, The American review of respiratory disease,
Copied contents to your clipboard!